SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-021043
Filing Date
2023-03-17
Accepted
2023-03-17 16:38:58
Documents
59
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1222_lucyscien.htm   iXBRL 10-Q 1057728
2 CERTIFICATION f10q1222ex31-1_lucyscien.htm EX-31.1 10572
3 CERTIFICATION f10q1222ex31-2_lucyscien.htm EX-31.2 10371
4 CERTIFICATION f10q1222ex32-1_lucyscien.htm EX-32.1 3990
5 CERTIFICATION f10q1222ex32-2_lucyscien.htm EX-32.2 4003
  Complete submission text file 0001213900-23-021043.txt   3948828

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lsdi-20221231.xsd EX-101.SCH 39566
7 XBRL CALCULATION FILE lsdi-20221231_cal.xml EX-101.CAL 29424
8 XBRL DEFINITION FILE lsdi-20221231_def.xml EX-101.DEF 167385
9 XBRL LABEL FILE lsdi-20221231_lab.xml EX-101.LAB 360036
10 XBRL PRESENTATION FILE lsdi-20221231_pre.xml EX-101.PRE 181030
53 EXTRACTED XBRL INSTANCE DOCUMENT f10q1222_lucyscien_htm.xml XML 279088
Mailing Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6
Business Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6 778-410-5195
Lucy Scientific Discovery, Inc. (Filer) CIK: 0001865127 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41616 | Film No.: 23743242
SIC: 2834 Pharmaceutical Preparations